Kathleen G. Lomax

Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial

Paul Rutgeerts, Gert Van Assche, William J. Sandborn et al. · Gastroenterology · 2012 · 575 citations

Inflammation, Chronic Inflammatory Diseases, Anti-inflammatory +10

Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM Study

Brian G. Feagan, Remo Panaccione, William J. Sandborn et al. · Gastroenterology · 2008 · 371 citations · Full text

Charm Study, Gastroenterology, Adalimumab Therapy +5

Adalimumab for the treatment of fistulas in patients with Crohn’s disease

J F Colombel, David A. Schwartz, William J. Sandborn et al. · Gut · 2009 · 351 citations · Full text

Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease

Stefanie Schreiber, Walter Reinisch, J F Colombel et al. · Journal of Crohn s and Colitis · 2012 · 187 citations

The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy

Simon Lichtiger, DG Binion, Douglas C. Wolf et al. · Alimentary Pharmacology & Therapeutics · 2010 · 184 citations · Full text